Supplementary Table S2 Correlation between pre-operative plasma miR-451 or miR-486 concentrations and clinicopathologic features in gastric cancer patients.

Slides:



Advertisements
Similar presentations
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
Advertisements

Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
Musculoskeletal Oncology Service, National Cancer Center Hospital Musculoskeletal Oncology Service, Keio University Hospital An Analysis of Clinicopathological.
Ct value Log concentration miR-375 miR-221 Supplementary Figure S1.
Xenograft TDDoxorubicinCisplatinIfosfamide SGDT/C%EfficacySGDT/C%EfficacySGDT/C%Efficacy OHS > CTPX > SBX6, >
© 2008 Luzerner Kantonsspital Advanced Pancreatic Cancer Swiss Tumorboard, Berne PD Dr. J. Metzger Chefarzt.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Table S1. Demographics and Patient Pathology Results Total number of patients40 Male (%)29 (72%) Female (%)11 (28%) Age Range47 – 86 Median Age70 Organ.
Supplementary table 1 Supplementary table 1. Clinical-pathological features of the resection-only and chemotherapy/resection stage II/III colorectal cancer.
Supplementary table 1 miR-506 expression and clinocopathological factors FactorsTotal number miR-506 low expressionmiR-506 high expression P-value (n =
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
Supplementary Table 1: Clinicopathologic characteristics of 100 patients with invasive breast cancer Clinical characteristicsNumber of cases (%) Median.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
GI conference Case 3 Stomach and liver F/69 S
Department of Pathology R3 NKY Case 1.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Norwegian register for general thoracic surgery.
Norwegian register for general thoracic surgery.
AOC Surgical Outcome Survey
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
Short-term outcome of neo-adjuvant chemotherapy
Insert Footer or Copyright Information Here
Number of brain metastasis
R. Michelle Sarin, MD Mentor: Jeffrey Fowler, MD
Operative Approach and
Discussion & Conclusion Predictives of Meningioma Grading
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Characteristics IgAN (n=28) ADPKD (n=37) Male (percentage) 21 (75.0)
Volume 144, Issue 4, Pages (October 2013)
Circulating microRNAs as novel minimally invasive biomarkers for breast cancer Supplementary Information Helen M. Heneghan1, Nicola Miller1, Aoife J.
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Prognosis of younger patients in non-small cell lung cancer
Marcelo Calil Instituto Brasileiro de Controle do Câncer
Table (1):Relation between lymph node and molecular subtypes.
Supplementary Table 1. (A) S100β Validation set (n=76 ER-positive and ER-negative patients). (B) S100β Validation set (n=59 ER-positive patients). Association.
Follow-up duration (month)
Clinicopathological features of colorectal cancer patients among KRAS wild type, p.G13D and other mutations: Results from a multicenter, cross-sectional.
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
NSABP Protocol C-08 Ming He MD.
BMI (kg/m2)   <23, n (%) 23–25, n (%) ≥25, n (%) p value 177 (40.7)
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Fig. S1 PIPKI is highly expressed in cancer cell lines
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
E13-01: Insights into thymic epithelial tumor: pathology
Volume 61, Issue 5, Pages (May 2012)
UHRF1 is regulated by miR-9 in colorectal cancer
高雄長庚 大腸直腸外科 吳昆霖 盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全
Volume 67, Issue 6, Pages (June 2015)
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
Surgical Treatment of Metachronous Second Primary Lung Cancer
National Cancer Statistics in Korea, 2015
Dandan Wang et al. BTS 2018;3: Down-Regulation of miR-24 in Response to Insulin Infusion in Human Plasma Human plasma insulin (A), glucose (B),
Fig.1. The dose of GH administered to patients in different age groups after 1 year of GH replacement therapy. Data are shown as mean, median and 10th-90th.
Repke J Snijder, Aart Brutel de la Rivière, Hans J. J Elbers, Jules M
Does Liver Regeneration Increase the Postoperative HCC Recurrence after Curative Resection ? Jin-Ho Lee, MD. Department of Surgery, Yonsei University.
Table S1: Characteristics of the cancer patients
Endoscopic Submucosal Dissection of Early Cancers, Flat Adenomas, and Submucosal Tumors in the Gastrointestinal Tract  Andreas Probst, Daniela Golger,
Fig. 1 A Fig. 1. Simple linear regression of plasma (A) testosterone (pg/mL), (B) 11-ketotestosterone (pg/mL), (C) 17b-estradiol (pg/mL) and (D) calcium.
Bile duct invasion itself can be the prognosis factor in early HCC
Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D
Correlation between serum visfatin concentrations and the clinical stage (A) and tumor size (B, C) of HCCs. A and B, the correlations were determined by.
Surgical resection of metachronous liver metastases
Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.
median of follow-up (month)
Presentation transcript:

Supplementary Table S2 Correlation between pre-operative plasma miR-451 or miR-486 concentrations and clinicopathologic features in gastric cancer patients N Mir-451 a P Mir-486 a Sex Male 31 9.03 (2.87-12.36) 0.26 (0.11-0.38) Female 25 4.16 (2.66-10.34) 0.181 0.25 (0.13-0.49) 0.315 Age (y) median   66 (35-87)  <60 15 8.88 (2.72-12.45) 0.28 (0.19-0.33) 60≦ 41 6.09 (2.74-11.06) 0.265 0.22 (0.10-0.49) 0.248 Tumor size (cm) <5 29 9.03 (2.66-13.63) 0.28 (0.14-0.39) 5≦ 27 5.17 (2.80-9.78) 0.168 0.22 (0.11-0.44) 0.316 Histological type Well 34 8.53 (2.72-12.46) 0.30 (0.13-0.47) Poor 22 5.43 (2.77-10.23) 0.276 0.21 (0.12-0.37) 0.321 lymphatic invasion b - 28 9.46 (4.15-13.64) 0.30 (0.15-0.38) + 24 5.03 (2.42-10.28) 0.039 0.23 (0.08-0.56) 0.318 venous invasion b 8.04 (2.66-13.63) 0.28 (0.15-0.39) 6.09 (2.96-11.42) 0.262 0.26 (0.10-0.50) 0.356 pT stage m, sm 21 9.89 (3.08-13.63) 0.31(0.16-0.57) Others 35 5.17 (2.70-10.52) 0.100 0.19 (0.11-0.41) 0.127 pN stage 9.96 (3.80-13.34) 0.30 (0.16-0.57) 5.03 (2.66-10.63) 0.053 0.21 (0.11-0.44) 0.234 pTMN stage Ⅰ+Ⅱ 33 9.03 (4.15-13.63) 0.31 (0.14-0.43) Ⅲ+Ⅳ 23 3.86 (2.53-9.29) 0.016 0.19 (0.08-0.38) 0.135 recurrence b,c 8.04 (3.47-13.05) 0.32 (0.14-0.56) 12 7.02 (2.98-11.33) 0.341 0.23 (0.12-0.33) 0.129 residual tumor 47 8.04 (3.04-12.45) 0.31 (0.14-0.46) 9 2.74 (1.70-4.89) 0.011 0.10 (0.07-0.22) 0.018 a: Median of concentration (amol/μl) (with 25th-75th percentile) b: 4 cases could not be resected  c: 5 cases with residual tumor after operation